Bloomberg Business

Amgen’s $27.8 Billion Horizon Takeover Allowed in FTC Accord

Amgen Inc. can move forward with its $27.8 billion takeover of Horizon Therapeutics Plc after the US Federal Trade Commission said Friday that it accepted a binding settlement that the combined company won’t bundle together two of Horizon’s blockbuster drugs.

Close Bitnami banner
Bitnami